banchan oi sobagi
Selected indexed studies
- Current Overview of Osteogenesis Imperfecta. (Medicina (Kaunas), 2021) [PMID:34068551]
- Update on the Genetics of Osteogenesis Imperfecta. (Calcif Tissue Int, 2024) [PMID:39127989]
- Osteogenesis imperfecta: pathogenesis, classification, and treatment. (Clin Pediatr Endocrinol, 2025) [PMID:40636817]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Current Overview of Osteogenesis Imperfecta. (2021) pubmed
- Update on the Genetics of Osteogenesis Imperfecta. (2024) pubmed
- Osteogenesis imperfecta: pathogenesis, classification, and treatment. (2025) pubmed
- 4-Octyl itaconate restricts STING activation by blocking its palmitoylation. (2023) pubmed
- Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. (2014) pubmed
- Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types. (2022) pubmed
- 4-Octyl itaconate attenuates LPS-induced acute kidney injury by activating Nrf2 and inhibiting STAT3 signaling. (2023) pubmed
- COL1A1- and COL1A2-Related Osteogenesis Imperfecta. (1993) pubmed
- Genotype-phenotype relationship and comparison between eastern and western patients with osteogenesis imperfecta. (2024) pubmed
- DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum. (2016) pubmed